Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Current Assets (2024 - 2025)

Carlsmed's Current Assets history spans 2 years, with the latest figure at $126.7 million for Q4 2025.

  • For Q4 2025, Current Assets rose 156.68% year-over-year to $126.7 million; the TTM value through Dec 2025 reached $126.7 million, up 156.68%, while the annual FY2025 figure was $126.7 million, 156.68% up from the prior year.
  • Current Assets reached $126.7 million in Q4 2025 per CARL's latest filing, down from $131.5 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $131.5 million in Q3 2025 to a low of $46.2 million in Q2 2025.